US Patent Issued to SHANGHAI ZHIMENG BIOPHARMA on Aug. 11 for "Tetrahydroisoquinoline compound as potassium channel modulator and preparation and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,687, issued on Aug. 11, was assigned to SHANGHAI ZHIMENG BIOPHARMA INC. (Shanghai).

"Tetrahydroisoquinoline compound as potassium channel modulator and preparation and application thereof" was invented by Bo Liang (Shanghai), Gang Liu (Shanghai) and Huanming Chen (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "A tetrahydroisoquinoline compound as a potassium channel modulator and preparation and application thereof. Specifically, the compound has the structure as shown in formula A."

The patent was filed on Aug. 5, 2021, under Application No. 17/791,613.

*For further information, including images, charts and tables, please visit: http://p...